Latest awards bring Nextleaf's intellectual property portfolio to a total of eight (8) issued patents related to the extraction, refinement and purification of cannabinoids VANCOUVER, Sept. 18, 2019 /PRNewswire/ - Nextleaf Solutions Ltd. ("Nextleaf", "OILS", or the "Company") (CSE: OILS) (OTCQB: OILFF)

GENEVA, Switzerland, Sept. 18, 2019 /PRNewswire/ -- The European Society of Gynaecological Oncology (ESGO) and the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) will launch on Friday, Sep 20th, 2019 the first-ever World Gynecologic Oncology Day. This year's initiative aims to raise awareness and to highlight the r

LOS ANGELES, Sept. 18, 2019 /PRNewswire/ -- Seeking to revolutionize the oral care industry with an innovative toothbrush designed and developed by a team of top dental industry professionals—including the former director of engineering at Sonicare—Encompass (

NEW YORK, Sept. 18, 2019 /PRNewswire/ --  Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that the company's Chief Executive Of

DALLAS, Sept. 18, 2019 /PRNewswire/ -- Medecision, an integrated health management solutions company that supports the health and care of more than 50 million consumers nationwide, is excited t

ROYAL OAK, Mich., Sept. 18, 2019 /PRNewswire/ -- HED, a national integrated design and engineering firm, is pleased to announce the completion of the new Max and Debra Ernst Heart Center at&n

ATLANTA, Sept. 18, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in a fireside chat with analysts and investors at the upcoming Deutsche Bank 27th Annual Leveraged Finance Conference on Wednesday, September 25, 201

NEW YORK, Sept. 18, 2019 /PRNewswire/ -- The Mesothelioma Compensation Center says, "We have recommended attorney Erik Karst of t

JERSEY CITY, N.J., Sept. 18, 2019 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced completion of the last-patient/last-visit in its Phase 3 VANISH 303 study, and that it expects to release top-line data earlier than previously repo

IRVINE, Calif., Sept. 18, 2019 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport"), the world's leading temperature-controlled logistics solutions company dedicated to the life sciences industry, today announced the launch of its Advanced Therapy Shipper™ product line for the regenerative medicine market. The Advanced Therapy Shippe